Searching the public methylation databases obtained with methylation microarrays revealed hypermethylation of FLRT2 at the promoter in other major cancers, including prostate cancer, lung cancer, and breast cancer37, 38. This evidence concerns the gene FLRT2 and lung carcinoma.